Episodes

Communicable E4 - The BLING-3 trial & continuous beta-lactam infusion: should these results change your practice?

Episode 4 · July 1, 2024 · 44:52

Hosts Angela Huttner & Erin McCreary welcome Prof. David Paterson (Singapore) and Prof. Josh Davis (Newcastle, Australia) to discuss the design and results of the BLING-3 trial, whic...

Communicable E3 - The new WHO Priority Pathogens List: which bugs to target first?

Episode 3 · June 17, 2024 · 42:58

What are WHO's most wanted bacterial pathogens in 2024? Hosts Angela Huttner & Oana Sandulescu welcome guests Dr. Hatim Sati of the World Health Organisation (WHO) and Dr. Erin Duffy...

Communicable E2 - Phage therapy: does it work and will we have access?

Episode 2 · June 3, 2024 · 54:00

In this episode, hosts Josh Davis (Newcastle, Australia) and Angela Huttner (Geneva, Switzerland) interview the phage ‘microbiologist-clinician duo’, Drs. Shawna McCallin and Lorenz ...

Late-breaker clinical trial results from ESCMID Global 2024: Should they change your practice?

Episode 1 · May 10, 2024 · 58:02

CMI Communications editors Angela Huttner, Marc Bonten, and Erin McCreary discuss late-breaker clinical trials presented at ESCMID Global (ECCMID) in Barcelona, providing insights in...